Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults

NCT03738943 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Receptor Blockade

Interventions

DRUG: Adenosine Triphosphate
DRUG: Acetylcholine
DRUG: Sodium Nitroprusside
DRUG: Adenosine Diphosphate
DRUG: Adenosine Monophosphate
DRUG: Uridine Triphosphate
DRUG: Adenosine
DRUG: Vitamin B 6
DRUG: Pyridoxal 5'-Phosphate

Sponsor

Colorado State University